there is no doubt that neuren made the right choice. crazy who thinks to continue such delicate trials facing even the slightest risk of reporting mortality in execution. it is very different to suspend the trial in accordance with fda that the same intervenes and imposes the suspension by chance of mortality. perhaps it is not clear to many, but here in Italy you die very easily of covid 19. certainly neuren knows he has a healthy and safe trial and does not want to incur any external accident. now the market must prove that the title is also controlled to the downside keeping in the dollar. that it is clear that we are not registering a bankruptcy, but a delay for reasons unrelated to the compan
NEU Price at posting:
$1.11 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)